Tratamiento de la diabetes en mujeres embarazadas.
Saved in:
| Title: | Tratamiento de la diabetes en mujeres embarazadas. |
|---|---|
| Alternate Title: | Diabetes therapy in pregnant women. Traitement du diabète dans la grossesse et la femme adulte. Tratamento da diabetes em mulheres grávidas. |
| Authors: | Zárate, Arturo1 zaratre@att.net.mx, Valencia, Marcelino Hernández1, Basurto, Lourdes1, Saucedo, Renata1 |
| Source: | Ginecología y Obstetricia de México. abr2008, Vol. 76 Issue 4, p211-216. 6p. 4 Graphs. |
| Subjects: | GESTATIONAL diabetes, PRENATAL care, MATERNAL health, CARDIOVASCULAR diseases in pregnancy, HYPERGLYCEMIA, FETAL death, THERAPEUTICS |
| Abstract (English): | Diabetes type 2 has increased in adult women due to higher frequency of obesity and sedentary lifestyle, and thus cardiovascular diseases have increased. Hyperglycemia control and, collaterally, high blood pressure and dyslipidemia correction are the basis of its therapy. This paper evaluates oral antidiabetic drugs effectiveness and preference. Gestational diabetes is a cause of morbidity and mortality in fetuses and newborns, it has to be timely diagnosed, and needs a strict control, same to diabetes type 1. Gyneco-obstetrical doctor must be alert to diabetes signs and closely work in its therapy. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): | La diabetes tipo 2 se ha incrementado en la mujer adulta debido a la mayor frecuencia de obesidad y sedentarismo, lo que repercute en mayor enfermedad cardiovascular. El fundamento de su tratamiento es el control de la hiperglucemia y, de forma colateral, la corrección de la hipertensión arterial y dislipoproteinemia para evitar las complicaciones tardías de orden vascular. En este trabajo se evalúa la eficacia y preferencia de los antidiabéticos orales así como su procedimiento de vigilancia. La diabetes gestacional es una causa de morbilidad y mortalidad fetal y del recién nacido que debe diagnosticarse oportunamente y requiere un control estricto, semejante al que se establece con la diabetes tipo 1. El ginecoobstetra debe estar alerta a la manifestación de diabetes y colaborar estrechamente en el tratamiento de la enfermedad. [ABSTRACT FROM AUTHOR] |
| Abstract (French): | Le diabète type 2 s'est incrémenté chez la femme adulte en raison d'une fréquence majeure d'obésité et sédentarisme, ce qui répercute sur plus de maladie cardiovasculaire. Le fondement de son traitement est le contrôle de l'hyperglycémie et, de façon collatérale, la correction d'hypertension artérielle et dyslipoprotéinémie afin d'éviter des complications tardives de caractère vasculaire. Dans ce travail on évalue l'efficacité et préférence des antidiabétiques oraux ainsi que leur procédé de surveillance. Le diabète gestationnel est une cause de morbidité et mortalité foetal et du nouveau-né qui doit être diagnostiqué de manière opportune et il requiert d'un contrôle strict, pareil à celui qui s'établit avec le diabète type 1. Le gynéco-obstétricien doit être attentif à la manifestation du diabète et collaborer étroitement dans le traitement de la maladie. [ABSTRACT FROM AUTHOR] |
| Abstract (Portuguese): | A diabetes tipo 2 acrescentou-se na mulher adulta devido à maior freqüência de obesidade e sedentarismo o que repercute em maior doença cardiovascular. O fundamento do seu tratamento é o controle da hiperglicemia e, de forma colateral, a correlação da hipertensão arterial e dislipoproteinemia para evitar as complicações tardias de ordem vascular. Neste trabalho se avalia a eficácia e preferência dos antidiabéticos orais assim como seu procedimento de vigilância. A diabetes gestacional é uma causa de morbilidade e mortalidade fetal e do neonato que deve-se diagnosticar oportunamente e precisa de um controle estrito, semelhante ao estabelecido com a diabetes tipo 1. O ginecologista deve estar alerta à manifestação de diabetes e colaborar estreitamente no tratamento da doença. [ABSTRACT FROM AUTHOR] |
| Copyright of Ginecología y Obstetricia de México is the property of Federacion Mexicana de Ginecologia y Obstetricia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | MedicLatina |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: lth DbLabel: MedicLatina An: 31846692 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tratamiento de la diabetes en mujeres embarazadas. – Name: TitleAlt Label: Alternate Title Group: TiAlt Data: Diabetes therapy in pregnant women.<br />Traitement du diabète dans la grossesse et la femme adulte.<br />Tratamento da diabetes em mulheres grávidas. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zárate%2C+Arturo%22">Zárate, Arturo</searchLink><relatesTo>1</relatesTo><i> zaratre@att.net.mx</i><br /><searchLink fieldCode="AR" term="%22Valencia%2C+Marcelino+Hernández%22">Valencia, Marcelino Hernández</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Basurto%2C+Lourdes%22">Basurto, Lourdes</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Saucedo%2C+Renata%22">Saucedo, Renata</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Ginecología+y+Obstetricia+de+México%22">Ginecología y Obstetricia de México</searchLink>. abr2008, Vol. 76 Issue 4, p211-216. 6p. 4 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22GESTATIONAL+diabetes%22">GESTATIONAL diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22PRENATAL+care%22">PRENATAL care</searchLink><br /><searchLink fieldCode="DE" term="%22MATERNAL+health%22">MATERNAL health</searchLink><br /><searchLink fieldCode="DE" term="%22CARDIOVASCULAR+diseases+in+pregnancy%22">CARDIOVASCULAR diseases in pregnancy</searchLink><br /><searchLink fieldCode="DE" term="%22HYPERGLYCEMIA%22">HYPERGLYCEMIA</searchLink><br /><searchLink fieldCode="DE" term="%22FETAL+death%22">FETAL death</searchLink><br /><searchLink fieldCode="DE" term="%22THERAPEUTICS%22">THERAPEUTICS</searchLink> – Name: Abstract Label: Abstract (English) Group: Ab Data: Diabetes type 2 has increased in adult women due to higher frequency of obesity and sedentary lifestyle, and thus cardiovascular diseases have increased. Hyperglycemia control and, collaterally, high blood pressure and dyslipidemia correction are the basis of its therapy. This paper evaluates oral antidiabetic drugs effectiveness and preference. Gestational diabetes is a cause of morbidity and mortality in fetuses and newborns, it has to be timely diagnosed, and needs a strict control, same to diabetes type 1. Gyneco-obstetrical doctor must be alert to diabetes signs and closely work in its therapy. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Abstract (Spanish) Group: Ab Data: La diabetes tipo 2 se ha incrementado en la mujer adulta debido a la mayor frecuencia de obesidad y sedentarismo, lo que repercute en mayor enfermedad cardiovascular. El fundamento de su tratamiento es el control de la hiperglucemia y, de forma colateral, la corrección de la hipertensión arterial y dislipoproteinemia para evitar las complicaciones tardías de orden vascular. En este trabajo se evalúa la eficacia y preferencia de los antidiabéticos orales así como su procedimiento de vigilancia. La diabetes gestacional es una causa de morbilidad y mortalidad fetal y del recién nacido que debe diagnosticarse oportunamente y requiere un control estricto, semejante al que se establece con la diabetes tipo 1. El ginecoobstetra debe estar alerta a la manifestación de diabetes y colaborar estrechamente en el tratamiento de la enfermedad. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Abstract (French) Group: Ab Data: Le diabète type 2 s'est incrémenté chez la femme adulte en raison d'une fréquence majeure d'obésité et sédentarisme, ce qui répercute sur plus de maladie cardiovasculaire. Le fondement de son traitement est le contrôle de l'hyperglycémie et, de façon collatérale, la correction d'hypertension artérielle et dyslipoprotéinémie afin d'éviter des complications tardives de caractère vasculaire. Dans ce travail on évalue l'efficacité et préférence des antidiabétiques oraux ainsi que leur procédé de surveillance. Le diabète gestationnel est une cause de morbidité et mortalité foetal et du nouveau-né qui doit être diagnostiqué de manière opportune et il requiert d'un contrôle strict, pareil à celui qui s'établit avec le diabète type 1. Le gynéco-obstétricien doit être attentif à la manifestation du diabète et collaborer étroitement dans le traitement de la maladie. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Abstract (Portuguese) Group: Ab Data: A diabetes tipo 2 acrescentou-se na mulher adulta devido à maior freqüência de obesidade e sedentarismo o que repercute em maior doença cardiovascular. O fundamento do seu tratamento é o controle da hiperglicemia e, de forma colateral, a correlação da hipertensão arterial e dislipoproteinemia para evitar as complicações tardias de ordem vascular. Neste trabalho se avalia a eficácia e preferência dos antidiabéticos orais assim como seu procedimento de vigilância. A diabetes gestacional é uma causa de morbilidade e mortalidade fetal e do neonato que deve-se diagnosticar oportunamente e precisa de um controle estrito, semelhante ao estabelecido com a diabetes tipo 1. O ginecologista deve estar alerta à manifestação de diabetes e colaborar estreitamente no tratamento da doença. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Ginecología y Obstetricia de México is the property of Federacion Mexicana de Ginecologia y Obstetricia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=31846692 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: spa Text: Spanish PhysicalDescription: Pagination: PageCount: 6 StartPage: 211 Subjects: – SubjectFull: GESTATIONAL diabetes Type: general – SubjectFull: PRENATAL care Type: general – SubjectFull: MATERNAL health Type: general – SubjectFull: CARDIOVASCULAR diseases in pregnancy Type: general – SubjectFull: HYPERGLYCEMIA Type: general – SubjectFull: FETAL death Type: general – SubjectFull: THERAPEUTICS Type: general Titles: – TitleFull: Tratamiento de la diabetes en mujeres embarazadas. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zárate, Arturo – PersonEntity: Name: NameFull: Valencia, Marcelino Hernández – PersonEntity: Name: NameFull: Basurto, Lourdes – PersonEntity: Name: NameFull: Saucedo, Renata IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: abr2008 Type: published Y: 2008 Identifiers: – Type: issn-print Value: 03009041 Numbering: – Type: volume Value: 76 – Type: issue Value: 4 Titles: – TitleFull: Ginecología y Obstetricia de México Type: main |
| ResultId | 1 |